Graig Suvannavejh is a senior biotechnology and biopharmaceuticals analyst and Managing Director at Mizuho Securities, and is based in NYC. He brings over 20 years of sell-side biotech and pharmaceuticals equity research and investment banking experience, and also operational experience, having held business development/BD and corporate strategy roles at the global biopharma companies. He holds a PhD in Neuroscience from Northwestern University, and an undergraduate Biology and a Master’s in Physiology and Biophysics degree, both from Georgetown University.